Teladoc Health jumps after third-quarter revenue beats estimates

By Reuters News

** Shares of telehealth firm Teladoc Health TDOC.N rise 9.4% to $7.53 in extended trading

** Posts Q3 revenue of $605.10 million, above analysts' estimates of $588.5 million, according to data compiled by LSEG

** Company expects 2026 revenue in the range of $2.40 billion to $2.44 billion compared with analysts estimates of $2.41 billion

** Expects Q4 revenue in the range of $569 million to $615 million versus estimates of $597.39 million

** Stock down 1.7% YTD, as of last close

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk